These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 21421524
1. Collision tumors with synchronous presentation of breast carcinoma and lymphoproliferative disorders in the axillary nodes of patients with newly diagnosed breast cancer: a case series. Wahner-Roedler DL, Reynolds CA, Boughey JC. Clin Breast Cancer; 2011 Mar; 11(1):61-6. PubMed ID: 21421524 [Abstract] [Full Text] [Related]
2. Concurrent lymphoma and metastatic breast carcinoma in the axillary, confounding sentinel lymph-node biopsy. Benoit L, Arnould L, Collin F, Fraisse J, Cuisenier J, Chauffert B. Eur J Surg Oncol; 2004 May; 30(4):462-3. PubMed ID: 15063904 [Abstract] [Full Text] [Related]
3. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma. Durak MG, Akansu B, Akin MM, Sevınç AI, Koçdor MA, Saydam S, Harmancioğlu O, Ellıdokuz H, Bekış R, Canda T. Turk Patoloji Derg; 2011 May; 27(3):189-95. PubMed ID: 21935867 [Abstract] [Full Text] [Related]
4. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. White RE, Vezeridis MP, Konstadoulakis M, Cole BF, Wanebo HJ, Bland KI. J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459 [Abstract] [Full Text] [Related]
5. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Pendas S, Dauway E, Cox CE, Giuliano R, Ku NN, Schreiber RH, Reintgen DS. Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202 [Abstract] [Full Text] [Related]
6. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma. Kuru B, Bozgul M. Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1328-34. PubMed ID: 16997505 [Abstract] [Full Text] [Related]
7. [Management of the axilla in breast cancer: evidences and unresolved issues]. Fodor J, Polgár C, Péley G, Németh G. Orv Hetil; 2001 Sep 09; 142(36):1941-50. PubMed ID: 11680099 [Abstract] [Full Text] [Related]
8. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F. J Surg Oncol; 2004 Mar 09; 85(3):102-11. PubMed ID: 14991881 [Abstract] [Full Text] [Related]
10. Isolated retromammary lymph node metastasis of breast cancer without axillary lymph node involvement: a case report with a false-negative sentinel lymph node biopsy. Rokutanda N, Horiguchi J, Koibuchi Y, Nagaoka R, Sato A, Odawara H, Tokiniwa H, Iino Y, Hirato J, Takeyoshi I. Breast Cancer; 2009 Mar 09; 16(2):162-5. PubMed ID: 19242778 [Abstract] [Full Text] [Related]